Detalhe da pesquisa
1.
Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms.
Clin Cancer Res
; 27(12): 3456-3468, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33782031